A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.

Show other versions (1)

Bibliographic Details
Main Authors:	Le, Q, Wertheim, H, Tran, N, Van Doorn, H, Nguyen, T, Horby, P
Format:	Journal article
Language:	English
Published:	2010

Similar Items

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
by: Mai, L, et al.
Published: (2010)

Oseltamivir resistance during treatment of influenza A (H5N1) infection.
by: Jong, d, et al.
Published: (2005)

Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico
by: Luis Meave Gutiérrez-Mendoza, et al.

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
by: Makoto Ujike, et al.
Published: (2010-06-01)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
by: José Ernesto Ramirez-Gonzalez, et al.
Published: (2011-02-01)

Oseltamivir-resistant pandemic (H1N1)2009 in Yemen - case report
by: Al-Kohlani Abdulhakeem, et al.
Published: (2010-05-01)

Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009
by: Miller Joel C, et al.
Published: (2010-07-01)

Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
by: Taylor, W, et al.
Published: (2008)

Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out?
by: Thiago Moreno L Souza, et al.
Published: (2013-01-01)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
by: Peter K.C. Cheng, et al.
Published: (2009-06-01)

Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia
by: Hurt, A. C., et al.
Published: (2013)

Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
by: Nakamura, K, et al.
Published: (2010)

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: Opportunistic retrospective study of medical charts in China
by: Yu, H, et al.
Published: (2010)

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
by: Yu, H, et al.
Published: (2010)

Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients
by: Cameron Wolfe, et al.
Published: (2010-11-01)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
by: Liviana Da Dalt, et al.
Published: (2010-11-01)

Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic
by: Márcia Lúcia de Mário Marin, et al.
Published: (2010-01-01)

Oseltamivir resistance in influenza A (H5N1) infection - Reply
by: Jong, d, et al.
Published: (2006)

Subclinical avian influenza A(H5N1) virus infection in human, Vietnam.
by: Le, M, et al.
Published: (2013)

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
by: Makoto Ujike, et al.
Published: (2011-03-01)

Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus
by: Darling Melany de C. Madrid, et al.
Published: (2022-10-01)

Oseltamivir-Resistant Pandemic (H1N1) 2009 in Patient with Impaired Immune System
by: Grant A. Hill-Cawthorne, et al.
Published: (2010-07-01)

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
by: Samuel B. Graitcer, et al.
Published: (2011-02-01)

Emergence of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus within 48 Hours
by: Masafumi Inoue, et al.
Published: (2010-10-01)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
by: Itagaki Tsutomu, et al.
Published: (2010-03-01)

OSELTAMIVIR AS ANTIVIRAL THERAPY OF INFLUENZA A(H1N1)pdm09 IN CHILDREN AND ADULTS
by: L. V. Osidak, et al.
Published: (2016-09-01)

Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil
by: Camila Marx, et al.
Published: (2013-05-01)

Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil
by: Camila Marx, et al.
Published: (2013-05-01)

Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses.
by: Fox, A, et al.
Published: (2012)

Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11
by: Aaron D. Storms, et al.
Published: (2012-02-01)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
by: Margaret Okomo-Adhiambo, et al.
Published: (2015-01-01)

Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
by: Amytis Gholami, et al.
Published: (2022-08-01)

Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages
by: Treseder Travis W, et al.
Published: (2010-02-01)

Genomic Diversity of Oseltamivir-Resistant Influenza Virus A (H1N1), Luxembourg, 2007–08
by: Nancy A. Gerloff, et al.
Published: (2009-09-01)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
by: Mariana Baz, et al.
Published: (2018-11-01)

Subclinical Avian Influenza A(H5N1) Virus Infection in Human, Vietnam
by: Mai Quynh Le, et al.
Published: (2013-10-01)

2009 H1N1 Influenza
by: Seth J. Sullivan, MD; Robert M. Jacobson, MD; Walter R. Dowdle, PhD; and Gregory A. Poland
Published: (2011-04-01)

Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024
by: Mira C. Patel, et al.
Published: (2024-07-01)

Influenza A H5N1 and HIV co-infection: case report
by: Simmons Cameron, et al.
Published: (2010-06-01)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
by: Zhichao Xu, et al.
Published: (2022-06-01)